How to Buy Sight Sciences Stock
Sight Sciences Inc
Sight Sciences, Inc. , an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases.
Sight Sciences stock last closed at $3.46, down 2.26% from the previous day, and has decreased 55.35% in one year. It has underperformed other stocks in the Medical Devices industry by 0.32 percentage points. Sight Sciences stock is currently +70.44% from its 52-week low of $2.03, and -58.21% from its 52-week high of $8.28.
There are currently 51.7M SGHT shares outstanding. The market value of SGHT is $178.89M. In the past 24 hours, 106,000 SGHT shares were traded.
How to Buy Sight Sciences Stock
Wondering how to invest in Sight Sciences stock? Here's how.
- Choose where to buy Sight Sciences stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Sight Sciences stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Pick your payment method and add your information.
- Evaluate Sight Sciences stock: The Sight Sciences ticker symbol is SGHT. Is Sight Sciences stock a good investment? Should you buy shares of SGHT? How do SGHT's underlying business fundamentals look? Do top analysts think Sight Sciences is a good buy? Why has SGHT's stock price moved recently? (Hint: Our stock analysis website can help you figure out if SGHT is a good stock to buy).
- Place your SGHT buy order: Decide if you will purchase SGHT shares at the current market price or use a limit order to buy SGHT stock at a particular price.
- Get notifications regarding your investment in SGHT: Create a watchlist to monitor your new investment in Sight Sciences shares.
Step 1: Choose where to buy Sight Sciences stock
You will need a brokerage account in order to access the NASDAQ market and buy SGHT shares.
Our preferred brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Tech to Energy, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the right brokerage, you'll need to fill out some personal information so you are able to buy SGHT stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create your new brokerage account.
- Submit your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on the stock trading app, you need to deposit funds:
Check out this video walkthrough for more details transferring funds into your investment account.
Step 4: Evaluate Sight Sciences stock
Once you have selected the best place to buy Sight Sciences stock, it's important to evaluate their stock before you invest, so you can wrap your head around the risk and upside.
Sight Sciences shares at a glance
Sight Sciences Due Diligence Score
WallStreetZen was created to help average investors do more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on SGHT's stock page.
What is the fair value of SGHT stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge SGHT's intrinsic value.
Using relative valuations ratios:
- SGHT could be undervalued based on its P/B ratio of 2.3x, relative to Medical Devices industry P/B ratio of 4.1x
You can do additional valuation research on SGHT's stock here.
A look at SGHT Cashflows and Balance Sheet
Positive Financial Indicators:
- SGHT has $108.77M in cash and short term investments. This is enough to cover its annual cash burn of $24.44M.
- There are more short-term assets than short-term liabilities on the SGHT balance sheet.
- SGHT has cash burn of 24438000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the SGHT balance sheet.
Negative Financial Indicators:
- SGHT profit margin has gone up by 0.04 percentage points in the past year, but the company is still unprofitable.
- SGHT has a relatively high debt to equity ratio of 0.67.
Is SGHT stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 6 Wall Street analysts who give forecasts on SGHT, the consensus analyst rating on Sight Sciences is a Hold
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent SGHT Analyst Upgrades/Downgrades
Matthew O'Brien, a bottom 4% analyst from Piper Sandler maintains SGHT with a hold rating and lowers their SGHT price target from $5.50 to $3.50, on Mar 6, 2025.
You can dive deeper into what analysts are saying on the Sight Sciences stock forecast page.
SGHT Trading Indicators
SGHT Performance Metrics
Last year, SGHT revenue was $78.11M. During the past 4 year, SGHT's revenue has increased by 27.26% per year. This was faster than the Medical Devices industry average of 9.69%.
Dive into SGHT's earnings and revenue performance here.
Latest Insiders Trades at SGHT
In the past year, insiders at SGHT have bought more shares than they have sold.
David Badawi, Chief Technology Officer of SGHT, was the latest SGHT insider to buy. They bought $4,800.00 worth of SGHT shares on Jul 17, 2025.
Get more info about who owns SGHT shares here.
Can I rely on SGHT as an income stream?
No, Sight Sciences doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your SGHT buy order
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually the easiest way to buy. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a particular price, place a limit order.
Click the Open Trade button and your broker will execute the order.
If you need additional help with investing in stocks on eToro, watch the how to video below:
Step 6: Get notifications regarding your investment in SGHT
Now that you own some shares in SGHT, you'll want to keep up with your new shares.
Add SGHT to a watchlist to get notified of the latest news about your SGHT stock.
SGHT Feed
How to Buy Stock in Sight Sciences
To reiterate, here are the 6 steps you need to take to buy Sight Sciences stock right now:
- Choose where to buy Sight Sciences stock
- Sign up for a brokerage account
- Fund your brokerage account
- Evaluate Sight Sciences stock
- Place your SGHT buy order
- Get notifications regarding your investment in SGHT
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to monitor your new investment in Sight Sciences, hit the button below to create your watchlist.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.